LGVN (Longeveron Corp) יתרות המזומנים של החברה

סמלים רשמיים של חברת Longeveron (LGVN)

Longeveron Inc. capital flows are based on the development of anti-aging cell therapies designed to ensure future marginal income. The cash balance clearly confirms the current liquidity level, where 0.01 serves as the current parameter value. Share price growth depends on the success of clinical trials and patent purity, with Lomecel-B trials for Alzheimer's disease acting as the primary catalyst.

מזומנים ושווי מזומנים של החברה: Longeveron Corporation (LGVN) עבור 04.07.2022 - 21.11.2026

פילוחים אנליטיים ודוחות נתונים של חברת Longeveron Inc (LGVN)

- שווי מניות ותחזית קונצנזוס למחירים:
- מדדי הערכת שווי שוק של העסק:
אנליטיקה מסכמת של החברה:longeveron.com
פריט של המותג Longeveron

Conservative capital demands absolute liquidity transparency to assess business viability during periods of zero revenue. This indicator measures the volume of available cash, allowing investors to calculate the burn rate and forecast the date of a potential cash crunch. For Longeveron Inc., which is developing costly cell therapy, this level of cash reserves confirms the company's ability to fund prolonged clinical trials prior to the commercialization of its patents.